Why Is Motpoly XR So Hard to Find? [Explained for 2026]

If you've tried to fill your Motpoly XR prescription only to find empty shelves or a pharmacist shaking their head, you're not alone. Motpoly XR — the once-daily extended-release form of lacosamide — is a relatively new medication, and many patients are surprised to find it harder to locate than they expected. In this guide, we break down exactly why Motpoly XR can be difficult to find and what steps you can take right now.

What Is Motpoly XR and Why Is It Different?

Motpoly XR is the brand name for lacosamide extended-release capsules, manufactured by Aucta Pharmaceuticals. It was FDA-approved on May 4, 2023, making it one of the newer antiepileptic drugs (AEDs) on the market. Unlike its predecessor Vimpat (lacosamide immediate-release), which requires twice-daily dosing, Motpoly XR is taken just once daily — a major convenience advantage for patients managing epilepsy.

Motpoly XR comes in 100 mg, 150 mg, and 200 mg extended-release capsules. It is approved for adults and children weighing at least 110 pounds (50 kg) for the treatment of partial-onset seizures. In June 2024, the FDA expanded its indication to also include adjunctive treatment of primary generalized tonic-clonic (PGTC) seizures. It is a federally controlled substance (Schedule V), which adds another layer of complexity when filling prescriptions.

Is There an Official Motpoly XR Shortage?

As of 2026, there is no active FDA-declared shortage of Motpoly XR. However, "no FDA shortage" does not mean every pharmacy keeps it in stock. Because Motpoly XR is a newer brand-name-only medication with no generic equivalent, many pharmacies simply don't stock it routinely. Pharmacies typically order based on local demand — and because Motpoly XR is still gaining prescriber adoption, demand at any one pharmacy may be low enough that they don't keep it on hand.

This means the problem isn't a national supply disruption — it's a stocking and distribution issue. The drug exists, but your specific pharmacy may not order it unless they know patients need it.

Why Don't More Pharmacies Stock Motpoly XR?

Several factors explain why Motpoly XR is less consistently stocked than older AEDs:

It's brand-name only. No FDA-approved generic version of Motpoly XR exists. Brand-name drugs with high list prices (around $1,143–$1,565 per month at retail) may be ordered less frequently because fewer patients pay cash for them.

It's relatively new. Approved in 2023, Motpoly XR hasn't had years to build the prescriber base and pharmacy demand that older drugs like levetiracetam enjoy. Pharmacies stock what they know will move.

It's a Schedule V controlled substance. Controlled substance stocking requires additional recordkeeping. Some smaller pharmacies prefer not to carry low-volume controlled substances.

Insurance prior authorization barriers. Many insurance plans require a prior authorization (PA) before covering Motpoly XR. If a pharmacy sees many PA denials or delays, they may reduce stocking levels.

The Insurance Coverage Problem

Insurance coverage is often the biggest hurdle for Motpoly XR patients. Because Motpoly XR is a brand-name medication at a premium price point, most insurance plans place it on Tier 3 or Tier 4 of their formulary — meaning higher copays. Many plans also require:

Prior authorization (PA) — your doctor must submit documentation justifying why you need Motpoly XR instead of a lower-tier AED.

Step therapy — you may be required to try (and fail) one or more cheaper AEDs before your insurer will cover Motpoly XR.

The good news: Aucta Pharmaceuticals offers a copay savings card that lets eligible commercially insured patients pay as little as $10 for a 30-day supply. Ask your doctor's office or pharmacist about this program.

38,224+ patients found their medications in stock

38K+

Find Motpoly XR In Stock Today →

How the Controlled Substance Status Complicates Things

Motpoly XR is classified as a Schedule V (CV) controlled substance by the DEA — the least restrictive schedule, but still regulated. This means pharmacies must track inventory carefully. In practice, this can mean:

Some small or independent pharmacies may not stock it at all

Quantities on hand may be limited

Calling ahead to check availability is always recommended for controlled substances

What Can You Do When You Can't Find Motpoly XR?

Here are actionable steps to take right now:

Call multiple pharmacies before giving up. Stock varies by location. Large chains (CVS, Walgreens, Walmart, Costco) are more likely to carry or quickly order it than small independents.

Ask the pharmacy to order it. Most pharmacies can order any non-shortage drug within 1–2 business days from their wholesaler. Just ask.

Use a medication finder service.

Talk to your doctor about a temporary bridge. If Motpoly XR is unavailable and you're running low, your neurologist may be able to prescribe Vimpat (lacosamide IR) as a temporary equivalent while you sort out access.

Try a mail-order pharmacy. Specialty and mail-order pharmacies (like those run by Express Scripts or CVS Caremark) often have better stock of newer brand-name drugs.

Skip the calls, skip the stress.

Find Motpoly XR In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Never Stop Motpoly XR Without Talking to Your Doctor

This is critical: do not stop taking Motpoly XR suddenly, even if you can't fill your prescription. Abruptly stopping any antiepileptic drug can trigger seizures that won't stop (status epilepticus), a life-threatening emergency. If you're having trouble filling your prescription, call your doctor's office immediately. They can often help with prior authorizations, samples, or a temporary alternative.

How medfinder Can Help

Calling pharmacy after pharmacy is stressful, especially when you're managing a seizure condition. medfinder is a service that calls pharmacies near you on your behalf to find which ones have your medication in stock. You provide your medication, dosage, and zip code — medfinder does the calling and texts you the results. It's a faster, less frustrating way to locate Motpoly XR without spending your morning on hold.

For more tips, read our guide on how to find Motpoly XR in stock near you.

Bottom Line

Motpoly XR isn't in a declared national shortage, but its brand-only status, novelty, controlled substance classification, and insurance hurdles make it genuinely harder to find than older AEDs. The key is knowing where to look, asking pharmacies to order it, and using resources like medfinder to speed up the process. You should never have to go without your seizure medication — the tools exist to help you find it.